Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Revenue (2016 - 2025)

Historic Revenue for Cardiff Oncology (CRDF) over the last 15 years, with Q3 2025 value amounting to $120000.0.

  • Cardiff Oncology's Revenue fell 2727.27% to $120000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $501000.0, marking a year-over-year decrease of 2728.59%. This contributed to the annual value of $683000.0 for FY2024, which is 3995.9% up from last year.
  • Cardiff Oncology's Revenue amounted to $120000.0 in Q3 2025, which was down 2727.27% from $121000.0 recorded in Q2 2025.
  • Over the past 5 years, Cardiff Oncology's Revenue peaked at $205000.0 during Q1 2024, and registered a low of $68000.0 during Q2 2021.
  • Moreover, its 5-year median value for Revenue was $120000.0 (2025), whereas its average is $119315.8.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 14698.8% in 2024, then tumbled by 4682.93% in 2025.
  • Cardiff Oncology's Revenue (Quarter) stood at $133000.0 in 2021, then decreased by 3.76% to $128000.0 in 2022, then rose by 21.88% to $156000.0 in 2023, then dropped by 3.21% to $151000.0 in 2024, then fell by 20.53% to $120000.0 in 2025.
  • Its Revenue was $120000.0 in Q3 2025, compared to $121000.0 in Q2 2025 and $109000.0 in Q1 2025.